AzTrials
AzTrials

HIVTest@WorkNCT04292002

Test@Work Study: Evaluation of Attitudes and Uptake Within Employee Health Checks in the Construction Industry

A study testing Test@Work in people with HIV, run by University of Nottingham at 1 site in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This project is called Test@Work. In this project the investigators will offer general health checks and tailored health advice to up to 650 employees in the construction industry at sites across the East Midlands. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
HIV
What is being tested?
Test@Work
Could I receive a placebo?
No, everyone receives an active treatment
How many people
456 participants
Where
1 siteUnited Kingdom
Study dates
17 Aug 2019to 31 May 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • employee of a company in construction or related industries
  • provides informed consent

Who cannot join

  • does not speak English

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • University of Nottingham

    Nottingham, NG72HA

Other trials in United Kingdom

About this study

Official title: Test@Work: Evaluation of Attitudes and Uptake Within Employee Health Checks in the Construction Industry

This project is called Test@Work. In this project the investigators will offer general health checks and tailored health advice to up to 650 employees in the construction industry at sites across the East Midlands. The investigators will assess reach and uptake, and evaluate the views and perceptions of employees, managers and the delivery team. Health checks will include Body Mass Index (BMI; weight/height), waist-to-hip ratio, blood pressure, mental health screen, sexual health consultation and an opt-in rapid screening test for human immunodeficiency virus (HIV). Employees will be provided with a resource pack with information and signposting around physical activity, diabetes risk, diet, and musculoskeletal health. A digital resource providing information and signposting about workplace health screening and HIV testing will be developed and provided to managers at the participating worksites 2 weeks before their health check event.

Employees will be offered an additional text messaging service involving receipt of a series of messages with advice around HIV and testing alongside general health information. Employees will complete post-health check exit questionnaires and an exit interview. Managers will complete a post-event evaluation questionnaire and post-event interview. Mixed-methods evaluation will include assessment of reach, uptake, and intervention implementation processes.

Read the detailed description

The investigators will collect evaluation data with employees and company representatives.

Employees: will complete exit-questionnaires and be invited to a brief exit interview.

The investigators will collect by anonymous questionnaire: age, gender, country of birth, ethnicity, postcode, sexual orientation, employment status (FT/PT, permanent, agency, contract worker), reasons for attending, health perceptions, prior HIV testing history, influence of work on health, perceptions of employers provision for health and wellbeing, perceptions towards HIV testing in the workplace, range of tests undertaken, views about the workplace health check and future health intentions. Personal identifiers will not be collected and questionnaire data will not be provided to employers. Those employees who agree to be interviewed after the health check will be invited to a brief independent confidential interview with the project researcher.

Company representatives: will complete brief post-event questionnaire and be invited to post-event interview

The investigators will ask about the organisational/employee profile, their perceptions of company provision for health and wellbeing, perceptions towards the usefulness of the implementation toolkit and towards HIV testing in the workplace, method of delivery and their confidence to support employees who disclose a positive test outcome, views about the workplace health check and future implementation intentions.

Conditions
HIV
Being tested
Test@Work
Keywords
workplace, health promotion, health screening, employees, health behaviour

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Test@WorkBehavioural

    Offer of a general health check including opt-in sexual health consultation and HIV testing, weight/height, Body Mass Index (BMI), blood pressure, mental health screen. Provision of tailored health advice and a resource pack with information and signposting.

Study groups in NCT04292002
Study groupRoleWhat they receive
Health ChecksExperimentalWorkplace health checks - in this intervention employees can select from a range of optional health checks/tests and receive tailored health advice and a health resource pack.
Receives: Behavioral: Test@Work

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Health check uptake

    Percentage of employees choosing to take a workplace health check from total employee population across all sites

    Measured: Rolling intervention delivery and data collection over 15 months

Secondary outcomes (5)
  1. reasons for attending

    Qualitative data collected on reasons for opting in to health check

    Measured: immediately post-event

  2. perceptions of employer's provision for health and wellbeing

    Qualitative data collected on perceptions towards employer

    Measured: immediately post-event

  3. perceptions towards HIV testing in the workplace

    Qualitative data collected on employee views towards HIV testing at work

    Measured: immediately post-event

  4. range of tests undertaken

    which of the optional checks/tests were taken by the employee

    Measured: during the health check, and qualitative data immediately post-event

  5. Employee demographic profile

    Age, Gender, country of birth, ethnicity, postcode, sexual orientation, employment status (full-time or part-time, permanent, agency, contract worker)

    Measured: At recruitment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Mar 2020
  2. Study start17 Aug 2019
  3. Primary completion30 Nov 2020
  4. Study completion31 May 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Model description
The investigators are looking at uptake and reach of general health checks offered to up to 650 employees in the construction industry.
Masking
None (open label)
Enrolment
456 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04292002
Sponsor's protocol ID
IN-UK-276-5347 HIV DVE
Acronym
Test@Work
Status last verified
Sep 2021
First submitted
6 Dec 2019
Last updated
20 Sep 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: The investigators are not collecting individual health outcomes as part of this study. The primary aim is to assess uptake and reach of this workplace health checks initiative. Anonymised qualitative data can be available on reasonable request.

Publications

  • Blake H, Somerset S, Evans C. Development and Fidelity Testing of the Test@Work Digital Toolkit for Employers on Workplace Health Checks and Opt-In HIV Testing. Int J Environ Res Public Health. 2020 Jan 6;17(1):379. doi: 10.3390/ijerph17010379.

    PubMed 31935985
  • Blake H, Somerset S, Whittingham K, Middleton M, Yildirim M, Evans C. WHIRL Study: Workplace Health Interprofessional Learning in the Construction Industry. Int J Environ Res Public Health. 2020 Sep 18;17(18):6815. doi: 10.3390/ijerph17186815.

    PubMed 32961985
  • Middleton M, Somerset S, Evans C, Blake H. Test@Work Texts: Mobile Phone Messaging to Increase Awareness of HIV and HIV Testing in UK Construction Employees during the COVID-19 Pandemic. Int J Environ Res Public Health. 2020 Oct 26;17(21):7819. doi: 10.3390/ijerph17217819.

    PubMed 33114546
  • Somerset S, Evans C, Blake H. Accessing Voluntary HIV Testing in the Construction Industry: A Qualitative Analysis of Employee Interviews from the Test@Work Study. Int J Environ Res Public Health. 2021 Apr 15;18(8):4184. doi: 10.3390/ijerph18084184.

    PubMed 33920943
  • Jones W, Somerset S, Evans C, Whittingham K, Middleton M, Blake H. Test@work: evaluation of workplace HIV testing for construction workers using the RE-AIM framework. BMC Public Health. 2021 Sep 24;21(1):1737. doi: 10.1186/s12889-021-11739-z.

    PubMed 34560853

Questions about this trial

What is this clinical trial studying?

A study testing Test@Work in people with HIV, run by University of Nottingham at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Sep 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Health check uptake (time frame: Rolling intervention delivery and data collection over 15 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04292002, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Sep 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in